Network-level functional topological changes after mindfulness-based cognitive therapy in mood dysregulated adolescents at familial risk for bipolar disorder: a pilot study.

Bipolar disorder Emotion regulation Familial risk Graph theory Mindfulness-based intervention Psychoradiology Resting-state functional magnetic resonance imaging

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 27 01 2021
accepted: 09 04 2021
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 7 5 2021
Statut: epublish

Résumé

Given that psychopharmacological approaches routinely used to treat mood-related problems may result in adverse outcomes in mood dysregulated adolescents at familial risk for bipolar disorder (BD), Mindfulness-Based Cognitive Therapy for Children (MBCT-C) provides an alternative effective and safe option. However, little is known about the brain mechanisms of beneficial outcomes from this intervention. Herein, we aimed to investigate the network-level neurofunctional effects of MBCT-C in mood dysregulated adolescents. Ten mood dysregulated adolescents at familial risk for BD underwent a 12-week MBCT-C intervention. Resting-state functional magnetic resonance imaging (fMRI) was performed prior to and following MBCT-C. Topological metrics of three intrinsic functional networks (default mode network (DMN), fronto-parietal network (FPN) and cingulo-opercular network (CON)) were investigated respectively using graph theory analysis. Following MBCT-C, mood dysregulated adolescents showed increased global efficiency and decreased characteristic path length within both CON and FPN. Enhanced functional connectivity strength of frontal and limbic areas were identified within the DMN and CON. Moreover, change in characteristic path length within the CON was suggested to be significantly related to change in the Emotion Regulation Checklist score. 12-week MBCT-C treatment in mood dysregulated adolescents at familial risk for BD yield network-level neurofunctional effects within the FPN and CON, suggesting enhanced functional integration of the dual-network. Decreased characteristic path length of the CON may be associated with the improvement of emotion regulation following mindfulness training. However, current findings derived from small sample size should be interpreted with caution. Future randomized controlled trials including larger samples are critical to validate our findings.

Sections du résumé

BACKGROUND
Given that psychopharmacological approaches routinely used to treat mood-related problems may result in adverse outcomes in mood dysregulated adolescents at familial risk for bipolar disorder (BD), Mindfulness-Based Cognitive Therapy for Children (MBCT-C) provides an alternative effective and safe option. However, little is known about the brain mechanisms of beneficial outcomes from this intervention. Herein, we aimed to investigate the network-level neurofunctional effects of MBCT-C in mood dysregulated adolescents.
METHODS
Ten mood dysregulated adolescents at familial risk for BD underwent a 12-week MBCT-C intervention. Resting-state functional magnetic resonance imaging (fMRI) was performed prior to and following MBCT-C. Topological metrics of three intrinsic functional networks (default mode network (DMN), fronto-parietal network (FPN) and cingulo-opercular network (CON)) were investigated respectively using graph theory analysis.
RESULTS
Following MBCT-C, mood dysregulated adolescents showed increased global efficiency and decreased characteristic path length within both CON and FPN. Enhanced functional connectivity strength of frontal and limbic areas were identified within the DMN and CON. Moreover, change in characteristic path length within the CON was suggested to be significantly related to change in the Emotion Regulation Checklist score.
CONCLUSIONS
12-week MBCT-C treatment in mood dysregulated adolescents at familial risk for BD yield network-level neurofunctional effects within the FPN and CON, suggesting enhanced functional integration of the dual-network. Decreased characteristic path length of the CON may be associated with the improvement of emotion regulation following mindfulness training. However, current findings derived from small sample size should be interpreted with caution. Future randomized controlled trials including larger samples are critical to validate our findings.

Identifiants

pubmed: 33910549
doi: 10.1186/s12888-021-03211-4
pii: 10.1186/s12888-021-03211-4
pmc: PMC8080341
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

213

Références

Hum Brain Mapp. 2021 Feb 1;42(2):510-520
pubmed: 33068043
Neuropsychol Rev. 2014 Jun;24(2):77-87
pubmed: 24442602
Dev Psychol. 1997 Nov;33(6):906-16
pubmed: 9383613
Dev Cogn Neurosci. 2013 Jul;5:185-96
pubmed: 23590840
JAMA Psychiatry. 2018 Dec 1;75(12):1241-1251
pubmed: 30193355
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Neuropsychopharmacology. 2020 Mar;45(4):666-674
pubmed: 31812151
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11073-8
pubmed: 17576922
Bipolar Disord. 2010 Mar;12(2):116-41
pubmed: 20402706
Neuropsychopharmacology. 2019 Feb;44(3):629-634
pubmed: 30410014
Neuroimage. 2013 Oct 15;80:426-44
pubmed: 23643999
Brain. 2009 Dec;132(Pt 12):3366-79
pubmed: 19439423
Clin Psychol Rev. 2018 Feb;59:52-60
pubmed: 29126747
Aust N Z J Psychiatry. 2017 Dec;51(12):1220-1226
pubmed: 27742912
Neuroinformatics. 2016 Jul;14(3):339-51
pubmed: 27075850
J Clin Epidemiol. 2020 Oct;126:71-79
pubmed: 32561367
Front Neurosci. 2013 Feb 04;7:8
pubmed: 23382709
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Early Interv Psychiatry. 2020 Apr;14(2):211-219
pubmed: 31264800
Biol Psychiatry. 2017 Apr 15;81(8):718-727
pubmed: 28031150
Psychol Med. 2004 Oct;34(7):1309-18
pubmed: 15697057
J Clin Child Psychol. 1998 Dec;27(4):381-95
pubmed: 9866075
Science. 2010 Sep 10;329(5997):1358-61
pubmed: 20829489
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
J Am Acad Child Adolesc Psychiatry. 2019 Jan;58(1):61-71
pubmed: 30577940
Perspect Psychol Sci. 2011 Nov;6(6):537-59
pubmed: 26168376
Trends Cogn Sci. 2008 Mar;12(3):99-105
pubmed: 18262825
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Mol Psychiatry. 2018 Feb;23(2):413-421
pubmed: 27994220
Neurosci Biobehav Rev. 2018 Sep;92:172-186
pubmed: 29886175
Nat Rev Neurosci. 2015 Mar;16(3):159-72
pubmed: 25697159
Front Syst Neurosci. 2010 Jun 17;4:22
pubmed: 20592949
Nat Rev Neurosci. 2009 Mar;10(3):186-98
pubmed: 19190637
Neuropsychopharmacology. 2016 Dec;41(13):3016-3024
pubmed: 27356764
Behav Res Ther. 2016 Jan;76:32-9
pubmed: 26629933
Early Interv Psychiatry. 2016 Oct;10(5):426-34
pubmed: 25582800
Brain Connect. 2020 Sep;10(7):355-367
pubmed: 32458698
Front Hum Neurosci. 2015 Jun 30;9:386
pubmed: 26175682
Br J Psychiatry. 2012 May;200(5):359-60
pubmed: 22550328
Nat Rev Neurosci. 2015 Apr;16(4):213-25
pubmed: 25783612
Neuropsychopharmacology. 2017 Dec;42(13):2583-2592
pubmed: 28361870
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Neuroscience. 2018 Aug 21;386:295-308
pubmed: 30004009
Pediatrics. 1979 Oct;64(4):442-50
pubmed: 492809
Radiology. 2017 Mar;282(3):826-834
pubmed: 27779449
Neuroimage. 2011 Aug 1;57(3):1221-33
pubmed: 21609772
PLoS One. 2016 Mar 01;11(3):e0149297
pubmed: 26930284
J Abnorm Child Psychol. 2012 May;40(4):595-606
pubmed: 22113705
Front Hum Neurosci. 2013 Dec 26;7:910
pubmed: 24421764
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
Neuron. 2011 Nov 17;72(4):665-78
pubmed: 22099467
Neuroimage. 2018 Aug 1;176:489-498
pubmed: 29730491
J Clin Psychiatry. 2012 Oct;73(10):1328-34
pubmed: 23140652
Behav Res Ther. 1999 Jul;37 Suppl 1:S5-27
pubmed: 10402694
Front Hum Neurosci. 2013 Mar 01;7:54
pubmed: 23459637
Neuroimage. 2012 Jan 16;59(2):1404-12
pubmed: 21888983
Neuroimage. 2019 Apr 15;190:213-223
pubmed: 29223742
J Child Adolesc Psychopharmacol. 2016 May;26(4):372-9
pubmed: 26783833
PLoS Comput Biol. 2007 Feb 2;3(2):e17
pubmed: 17274684
Prev Sci. 2016 Jan;17(1):71-82
pubmed: 26297499
Bipolar Disord. 2014 Aug;16(5):523-30
pubmed: 23937313
Front Syst Neurosci. 2010 Jun 07;4:16
pubmed: 20589099
Front Neurosci. 2019 Jul 24;13:747
pubmed: 31396035
Phys Rev Lett. 2001 Nov 5;87(19):198701
pubmed: 11690461
Am J Psychiatry. 2017 Dec 1;174(12):1214-1222
pubmed: 28817956
Neurorehabil Neural Repair. 2017 Feb;31(2):190-201
pubmed: 27798379
Neuroimage Clin. 2015 May 21;8:398-407
pubmed: 26106565

Auteurs

Kun Qin (K)

Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.

Du Lei (D)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Jing Yang (J)

Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.

Wenbin Li (W)

Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Maxwell J Tallman (MJ)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Luis Rodrigo Patino Duran (LRP)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Thomas J Blom (TJ)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Kaitlyn M Bruns (KM)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Sian Cotton (S)

Department of Family and Community Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

John A Sweeney (JA)

Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Qiyong Gong (Q)

Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, China. qiyonggong@hmrrc.org.cn.
Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, China. qiyonggong@hmrrc.org.cn.
Functional and Molecular Imaging Key Laboratory of Sichuan Province, Chengdu, China. qiyonggong@hmrrc.org.cn.

Melissa P DelBello (MP)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH